Overview

Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer

Status:
Unknown status

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

This is a randomized phase II multicenter controlled study of oxaliplatin, calcium folinate, and 5-fluorouracil (mFOLFOX7) as neoadjuvant chemotherapy for resectable advanced gastric cancer. Hypothesis: Neoadjuvant chemotherapy may improve 5 year overall survival compared with the control.

Phase:

Phase 2

Details

Lead Sponsor:

Peking University

Collaborators:

Capital Medical University
Fudan University

Treatments:

Fluorouracil
Leucovorin
Levoleucovorin
Oxaliplatin